New International Survey Shows Pharmacists Key to Improving Patients' Health

LISBON, Portugal, August 30, 2010 - A new international survey shows that over 90% of pharmacists believe
they are key to improving patients' health, and while most pharmacists
surveyed see their responsibilities increasing, they voice concerns on
training and pay. The survey shows that almost 3 in 4 pharmacists (73%) now
provide patients with health promotion and management services. Nearly all (9
in 10) pharmacists agree that more information and advice - including on
specific medications and treatments - are expected from pharmacists than ever
before. However most pharmacists (78%) say that they are asked to provide
additional services, such as advice, without fair and proper compensation.

"Pharmacists' roles are changing, and we find ourselves increasingly
working with patients and other healthcare professionals to prevent and treat
disease. This survey shows that pharmacists welcome this expanded role, as it
highlights what they like doing most - helping deliver better patient
outcomes - while increasing visibility of pharmacists' expertise. However, we
also see an education and income gap that will need to be closed to ensure
the pressure on current pharmacists isn't too great, and so that we can
continue to attract the best and brightest to the profession in the future,"
said Ton Hoek, Chief Executive Officer of the International Pharmaceutical
Federation (FIP).Other results of the survey show the degree to which
pharmacists are concerned about the counterfeit medicines issue.

    - A solid majority (61%) say the prevalence of counterfeit medication
      is a serious issue in their country.
    - A solid majority (63%) believe current policies and technology are
      insufficient to deal with counterfeit medicines
    - Most (77%) believe medicine packages should have machine readable bar
      codes to ensure they are not counterfeit

Pfizer Inc. in collaboration with the International Pharmaceutical
Federation (FIP) commissioned APCO Insight to conduct an international survey
to better understand the needs, concerns and attitudes of pharmacists.
Interviews were held with over 2,000 community, retail and hospital
pharmacists in 8 countries (Australia, France, Germany, Italy, Portugal,
Turkey, the UK and the U.S.) between April and June 2010.

"Clearly pharmacists and the pharmaceutical industry share some similar
concerns relative to patient's health. We both want to ensure that
pharmacists have the right knowledge and tools to educate patients about
their medicine as well as to ensure patients receive safe, effective and
quality medicines, not counterfeit ones. Pfizer looks forward to continuing
to support, through appropriate channels, pharmacist education programs that
will ultimately translate into better outcomes for patients and healthcare
systems, globally", commented Dr. Emma Andrews, Director of External Medical
Affairs.

Notes to Editors

About the Survey

The survey and summary can be found here www.fip.org

About the International Pharmaceutical Federation (FIP)

The International Pharmaceutical Federation (FIP) is the global
federation of national associations of pharmacists and pharmaceutical
scientists in official relations with the World Health Organization (WHO),
dedicated to improving the access to and value of appropriate medicine use,
and contributing to changes in science, practice and health policies
worldwide. Through its 122 Member Organisations FIP represents and serves
more than two million pharmacists and scientists around the world.

About Pfizer, Inc.

Pfizer Inc: Working Together for a Healthier World(TM) At Pfizer, we
apply science and our global resources to improve health and well-being at
every stage of life. We strive to set the standard for quality, safety and
value in the discovery, development and manufacturing of medicines for people
and animals. Our diversified global health care portfolio includes human and
animal biologic and small molecule medicines and vaccines, as well as
nutritional products and many of the world's best-known consumer products.
Every day, Pfizer colleagues work across developed and emerging markets to
advance wellness, prevention, treatments and cures that challenge the most
feared diseases of our time. Consistent with our responsibility as the
world's leading biopharmaceutical company, we also collaborate with health
care providers, governments and local communities to support and expand
access to reliable, affordable health care around the world. For more than
150 years, Pfizer has worked to make a difference for all who rely on us. To
learn more about our commitments, please visit us at www.pfizer.com

About APCO Insight(R)

APCO Insight, a global opinion research and strategic communication
consultancy, works with many of the world's leading companies, associations,
nonprofits and public-sector organizations on a diverse range of
communication, reputation and issue management challenges.

Contact: International Pharmaceutical Federation: Ms Myriah Lesko or Mr Luc Besancon Telephone +31-70-302-1970; Email: press at fip.org; APCO Insight: Mr Phil Riggins UK Mobile Telephone +44(0)7733-318-204, Email: priggins at apcoworldwide.com